Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131884 · ClinicalTrials.gov registry record · NA
Pilot Study of Fosamax in Spinal Cord Injury
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01131884: Clinical Trial NA study, sponsored by University of Rochester.
NCT01131884 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01131884, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Study is designed to evaluate the efficacy of oral fosamax in prevention on osteoporosis in acute spinal cord injury. Efficacy will be measured by a duel energy X-Ray absorptiometry (DEXA) scan every 6 months. Patients will complete 3 visits, screening, 6 months, 12 months and be required to take oral fosamax versus placebo weekly.
Primary Outcome
Whether or not Fosamax increases bone mineral density at the hip and distal femur in spinal cord injury induced osteoporosis
Interventions
- DRUG Placebo
- DRUG Fosamax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-12 |
| Phase | NA |
Why NCT01131884 stopped before completion
NCT01131884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01131884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01131884 about?
NCT01131884 is a clinical study titled "Pilot Study of Fosamax in Spinal Cord Injury". Study is designed to evaluate the efficacy of oral fosamax in prevention on osteoporosis in acute spinal cord injury. Efficacy will be measured by a duel energy X-Ray absorptiometry (DEXA) scan every 6 months. Patients will complete 3 visits, screening, 6 months, 12 months and be required to take or...
What is the current status of trial NCT01131884?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2010-06. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01131884?
The interventions under investigation include: Placebo (DRUG), Fosamax (DRUG).
Who is sponsoring clinical trial NCT01131884?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01131884's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia